Literature DB >> 7884230

High incidence of haemorrhagic colitis due to Escherichia coli O157 in one Scottish town: clinical and epidemiological features.

J C Sharp1, L D Ritchie, J Curnow, T M Reid.   

Abstract

Verotoxin-producing strains of Escherichia coli (VTEC), in particular serotype O157:H7, are now recognised as the major cause of haemorrhagic colitis and the haemolytic uraemic syndrome (HUS) in the U.K. and in North America, and increasingly so in other countries. Over a 3-year period (1989-1991), 16 cases of E. coli 0157 infection occurred in one town (Peterhead) in north-east Grampian. Four patients required admission to hospital, of whom three developed HUS. The bovine source of VTEC infection has now been clearly established with foodborne, waterborne, person-to-person and zoonotic transmission described. Despite extensive local enquiries, the source(s) of infection of the 16 cases in Peterhead was not established. Much still needs to be learned about the epidemiology, risk factors and long-term clinical sequelae of VTEC infection and HUS. Close collaboration between the medical and veterinary professions is of paramount importance in order to provide better understanding of the prevalence of E. coli O157 infection in cattle and the route(s) of transmission to humans.

Entities:  

Mesh:

Year:  1994        PMID: 7884230     DOI: 10.1016/s0163-4453(94)91381-1

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  2 in total

1.  Molecular characterization of diarrheagenic Escherichia coli strains from stools samples and food products in Colombia.

Authors:  Laura Cristina Rúgeles; Jing Bai; Aída Juliana Martínez; María Consuelo Vanegas; Oscar Gilberto Gómez-Duarte
Journal:  Int J Food Microbiol       Date:  2010-01-28       Impact factor: 5.277

Review 2.  Estimating the burden of foodborne diseases in Japan.

Authors:  Yuko Kumagai; Stuart Gilmour; Erika Ota; Yoshika Momose; Toshiro Onishi; Ver Luanni Feliciano Bilano; Fumiko Kasuga; Tsutomu Sekizaki; Kenji Shibuya
Journal:  Bull World Health Organ       Date:  2015-06-01       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.